Comfrey, coltsfoot and borage have a long history of therapeutic use, but have been implicated in safety issues due to the presence of unsaturated pyrrolizidine alkaloids (PAs). Consequently, a range of regulatory restrictions on their use have been put in place in many places where these plants are used. The review conducted by this research team examined both published case reports as well as data from the WHO adverse events database, and demonstrated that there are multiple factors which cloud the understanding around the human safety of these three medicinal plants.
|Publication status||Published - Sep 2019|
|Event||Naturopaths and Medical Herbalists of New Zealand Annual Conference - Wellington, New Zealand|
Duration: 28 Sep 2019 → 29 Sep 2019
|Conference||Naturopaths and Medical Herbalists of New Zealand Annual Conference|
|Period||28/09/19 → 29/09/19|